Low-Dose Plerixafor is Effective and Less Costly for Peripheral Blood Stem Cell Mobilization in Patients with Lymphoma and Multiple Myeloma Undergoing Autologous Transplantation

Autologous Transplantation ◽

Blood Stem Cell ◽

Stem Cell Mobilization ◽

Faculty of 1000 evaluation for Plerixafor and G-CSF for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the prospective PREDICT trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.717958946.793470348 ◽

2013 ◽

Author(s):

Anskar Leung

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Steady State ◽

Peripheral Blood ◽

Blood Stem Cell ◽

Stem Cell Mobilization ◽

First Line ◽

Is absence of CD56 a predictive factor for peripheral blood stem cell mobilization failure in patients with multiple myeloma?

Journal of Clinical Apheresis ◽

10.1002/jca.21864 ◽

2020 ◽

Author(s):

Mesut Göçer ◽

Erdal Kurtoğlu

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Predictive Factor ◽

Peripheral Blood ◽

Blood Stem Cell ◽

Stem Cell Mobilization ◽

First experience of the use of a generic of plerixafor in peripheral blood stem cell mobilization in multiple myeloma and lymphoma patients

Transfusion and Apheresis Science ◽

10.1016/j.transci.2021.103070 ◽

2021 ◽

pp. 103070

Author(s):

M.A. Bekadja ◽

B. Mansour ◽

H. Ouldjeriouat ◽

B. Entasoltan ◽

S. Bouchama ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Peripheral Blood ◽

Blood Stem Cell ◽

Stem Cell Mobilization ◽

Biosimilar G-CSF (filgrastim) is effective for peripheral blood stem cell mobilization and non-cryopreserved autologous transplantation

Transfusion Clinique et Biologique ◽

10.1016/j.tracli.2013.04.109 ◽

2013 ◽

Vol 20 (5-6) ◽

pp. 502-504 ◽

Cited By ~ 6

Author(s):

N. Yafour ◽

M. Brahimi ◽

S. Osmani ◽

A. Arabi ◽

R. Bouhass ◽

...

Keyword(s):

Stem Cell ◽

Peripheral Blood ◽

Autologous Transplantation ◽

Blood Stem Cell ◽

Stem Cell Mobilization ◽

Current strategies for the management of autologous peripheral blood stem cell mobilization failures in patients with multiple myeloma

Journal of Clinical Apheresis ◽

10.1002/jca.21591 ◽

2017 ◽

Vol 33 (3) ◽

pp. 357-370 ◽

Cited By ~ 3

Author(s):

Ugur Sahin ◽

Taner Demirer

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Peripheral Blood ◽

Blood Stem Cell ◽

Stem Cell Mobilization ◽

Peripheral blood stem cell mobilization with a single dose of PEG-filgrastim in patients with multiple myeloma previously treated with radiotherapy

Leukemia & Lymphoma ◽

10.1080/10428194.2017.1300895 ◽

2017 ◽

Vol 58 (11) ◽

pp. 2724-2727

Author(s):

Alfonso T. Anguita-Compagnon ◽

Maria T. Dibarrart ◽

Laura Paredes ◽

Daniel Araos ◽

Marcela Vargas ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Single Dose ◽

Peripheral Blood ◽

Blood Stem Cell ◽

Stem Cell Mobilization ◽

Previously Treated ◽

Vinorelbine-Cyclophosphamide compared to cyclophosphamide in peripheral blood stem cell mobilization for multiple myeloma

Hematology/Oncology and Stem Cell Therapy ◽

10.1016/j.hemonc.2018.04.001 ◽

2018 ◽

Vol 11 (4) ◽

pp. 225-232 ◽

Cited By ~ 3

Author(s):

Sanjay de Mel ◽

Yunxin Chen ◽

Adeline Lin ◽

Teck Guan Soh ◽

Melissa Ooi ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Peripheral Blood ◽

Blood Stem Cell ◽

Stem Cell Mobilization ◽

Faculty of 1000 evaluation for Plerixafor and G-CSF for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the prospective PREDICT trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.717958946.793474527 ◽

2013 ◽

Author(s):

Nelson Chao

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Steady State ◽

Peripheral Blood ◽

Blood Stem Cell ◽

Stem Cell Mobilization ◽

First Line ◽

The Efficacy and Course of Peripheral Blood Stem Cell Mobilization in Patients with Multiple Myeloma

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2017.07.159 ◽

2017 ◽

Vol 17 ◽

pp. S341

Author(s):

Aleksandra Bogucka-Fedorczuk ◽

Justyna Rybka ◽

Mateusz Sawicki ◽

Magdalena Laszkowska-Lewko ◽

Katarzyna Wicherska-Pawłowska ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Peripheral Blood ◽

Blood Stem Cell ◽

Stem Cell Mobilization ◽

Peripheral blood stem cell mobilization in multiple myeloma patients treat in the novel therapy-era with plerixafor and G-CSF has superior efficacy but significantly higher costs compared to mobilization with low-dose cyclophosphamide and G-CSF

Journal of Clinical Apheresis ◽

10.1002/jca.21280 ◽

2013 ◽

pp. n/a-n/a ◽

Cited By ~ 1

Author(s):

Lubna Chaudhary ◽

Farrukh Awan ◽

Aaron Cumpston ◽

Sonia Leadmon ◽

Kathy Watkins ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Peripheral Blood ◽

Low Dose ◽

Stem Cell Mobilization ◽

The Novel ◽

Novel Therapy ◽

Superior Efficacy ◽